Implanet S.A.
IMPZY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$230.11M
Close$
$-0.07
184.1% downside
Current Fair Value
184.1% downsideOvervalued by 184.1% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $230.11 Million |
|---|---|
| Enterprise Value | $234.55 Million |
| Annual dividend | $0.00 |
| Earnings per Share | $0 |
| Beta | 0.63 |
| Outstanding Shares | 2,876,379,420 |
Return
| Return on Equity | 526.59% |
|---|---|
| Return on Assets | -51.11% |
| Return on Invested Capital | 701.99% |
Valuation & Multiples
| P/E Ratio | -5.3 |
|---|---|
| PEG | -258.28 |
| Price to Sales | - |
| Price to Book Ratio | -0.08 |
| Enterprise Value to Revenue | 9.42 |
| Enterprise Value to EBIT | -27.15 |
| Enterprise Value to Net Income | -26 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | -3.17 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Implanet S.A.
46 employees
CEO: Ludovic Lastennet
Implanet S.A., together with its associated companies, is dedicated to the research, development, manufacturing, and commercialization of spinal and orthopedic medical implants. The firm's product portfolio addresses both spinal and knee...